MedPath

Analysis of adverse events in voluntary platelet donors.

Completed
Conditions
Healthy platelet donors
Registration Number
CTRI/2020/10/028311
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Platelets are tiny blood cells that help our body to form clots to stop bleeding. Plateletpheresis or platelet donation is the procedure in which blood is drawn from a donor, platelets are separated and the remainder is returned to the donor.

The procedure is carried out on a machine, called cell separator. The procedure of plateletpheresis  is generally well tolerated and considered safe, involves minimal risk of adverse events. Adverse events of variable severity may occur during or after the plateletpheresis procedure. Adverse events can be divided into immediate & delayed and also local & systemic. Immediate reactions are the ones which are experienced by donor, when he /she is in hospital. Delayed reactions are those which are experienced by donor after leaving the hospital.  Immediate reactions like pain/ swelling at venepuncture site  etc.   are noted in apheresis register and are managed in  the hospital. But Delayed reactions generally go unnoticed.

In this study, the voluntary platelet donors willing to participate in the study are telephonically contacted between day 7- day 8 of their platelet donation and a set of questionnaire is asked to note down any delayed reactions he / she might have experienced.

Our Institute being an oncology center has around 4000 procedures of plateletpheresis  each year. Analysis of adverse events, immediate & delayed will help to understand susceptible donors, incidence of various adverse events. The study will also help in donor retention, improve donor safety, increase donation frequency & thereby maintaining platelet donor pool & supply.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
1000
Inclusion Criteria

The donors who fulfil the eligibility criteria for platelet donation, as per SOP, will be included in study.

Exclusion Criteria

The donors who do not fulfil eligibility criteria for platelet donation, as per SOP, will be excluded from the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study immediate & delayed adverse events in plateletpheresis donors.The adverse events experienced by platelet donors will be analysed over a period of 4 months
Secondary Outcome Measures
NameTimeMethod
To analyze factors associated with these adverse events if any.It will be analysed over a period of 4 months

Trial Locations

Locations (1)

Tata Memorial Hospital

🇮🇳

Mumbai, MAHARASHTRA, India

Tata Memorial Hospital
🇮🇳Mumbai, MAHARASHTRA, India
Dr Priti Desai
Principal investigator
9987815691
dr_priti99@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.